首页 > 最新文献

Biomedical research and clinical reviews最新文献

英文 中文
The Role of Mutations on Gene NAGA, in Schindler Syndrome NAGA基因突变在Schindler综合征中的作用
Pub Date : 2021-01-20 DOI: 10.31579/2692-9406/029
S. Asadi
Schindler syndrome is an inherited genetic disorder that mainly causes neurological problems. Schindler's syndrome is caused by a mutation in the NAGA gene, which is located in the long arm of chromosome 22 as 22q13.2.
辛德勒综合征是一种遗传性遗传疾病,主要引起神经系统问题。辛德勒综合征是由位于22号染色体长臂22q13.2的NAGA基因突变引起的。
{"title":"The Role of Mutations on Gene NAGA, in Schindler Syndrome","authors":"S. Asadi","doi":"10.31579/2692-9406/029","DOIUrl":"https://doi.org/10.31579/2692-9406/029","url":null,"abstract":"Schindler syndrome is an inherited genetic disorder that mainly causes neurological problems. Schindler's syndrome is caused by a mutation in the NAGA gene, which is located in the long arm of chromosome 22 as 22q13.2.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49586138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical Evaluation of Proximate, Vitamin and Amino Acid Profile of Leaf, Stem Bark and Root of Indigofera Tinctoria 靛蓝叶、茎、皮、根的近似值、维生素和氨基酸谱的化学评价
Pub Date : 2021-01-05 DOI: 10.31579/2692-9406/026
A. J.O
Medicinal plants contain substances with high therapeutic value because they contain multiple bioactive chemicals. Chemical analysis of Indigofera tinctoria leaves, stem bark and roots was evaluated. The result revealed that proximate composition of Indigofera tinctoria leaves contained 12.49 % moisture content (M.C), 87.51 % dry matter (DM), 30.53 % crude protein (CP), 19.02 % crude fibre (CF), 2.44 % ether extract (EE), 13.86 % ash, 36.59 % carbohydrate (CHO) and 254.1 kcal/100g energy (ME). Indigofera tinctoria stem bark contained M.C (6.40 %), DM (93.60 %), CP (5.11 %), CF (54.49 %), EE (2.00 %), ash (10.42 %), CHO (29.98 %) and ME (156.0 kcal/100g). Indigofera tinctoria roots contained MC, DM, CP, CF, EE, ash, CHO and ME at 10.04 %, 89.60 %, 8.22 %, 40.88 %, 1.21 %, 8.43 %, 42.47 % and 210.0 kcal/100g respectively. Vitamin analysis showed that Indigofera tinctoria leaves, stem bark and roots contained β- carotene (8.45, 2.88 and 5.11 mg/100 g), Vitamin B1 (1.94, 0.33 and 1.00 mg/100 g), Vitamin B2 (0.71, 0.21 and 0.50 mg/100 g), Vitamin B3 (0.66, 0.34 and 0.48 mg/100 g), Vitamin B6 (0.32, 0.21 and 0.30 mg/100 g), Vitamin B7 (0.63, 0.01 and 0.16 mg/100 g), Vitamin B9 (0.26, 0.10 and 0.18 mg/100 g), Vitamin B12 (0.21, 0.03 and 0.10 mg/100 g), Vitamin C (14.0, 3.56 and 9.44 mg/100 g), Vitamin D (0.10, 0.01 and 0.06 mg/100 g) and Vitamin K (0.17, 0.07 and 0.12 mg/100 g). Amino acid analysis revealed the presence of threonine, leucine, lysine, valine, tryptophan, glycine, phenylalanine, histidine, methionine, alanine, serine, proline, aspartate, glutamic acid, tryrosine and cysteine in Indigofera tinctoria leaves, stem bark and roots at (7.65 %, 1.22 % and 3.03 %), (5.76, 1.09 % and 2.46 %), (3.11 %, 1.21% and 2.00 %), (7.21 %, 3.53 % and 4.09 %), (1.45%, 0.03% and 1.00 %), (4.76 %, 0.08 % and 2.33 %), (6.33 %, 2.45 % and 3.49 %), (7.42 %, 2.00 % and 3.00 %), (3.49 %, 0.01 % and 2.00 %), (2.41 %, 0.56 % and 1.20 %), (5.23 %, 1.22 % and 1.76 %), (2.87 %, 0.57 % and 1.00 %), (5.32 %, 2.11 % and 3.56 %), (9.66 %, 4.21 % and 5.11 %), (2.45 %, 0.57 % and 1.67 %) and (1.85 %, 0.81 % and 0.89 %) respectively. It was concluded that Indigofera tinctoria leaves, stem bark and roots are loaded with significant quantity of nutrients, vitamins and amino acid (leaves ˃ roots ˃ stem bark).
药用植物含有多种生物活性化学物质,具有很高的治疗价值。对靛蓝的叶、茎、皮、根进行了化学分析。结果表明,紫靛蓝叶片的基本成分为12.49%的水分、87.51%的干物质、30.53%的粗蛋白质、19.02%的粗纤维、2.44%的粗脂肪、13.86%的灰分、36.59%的碳水化合物和254.1 kcal/100g能量。靛蓝茎皮中含有纤维素(6.40%)、DM(93.60%)、CP(5.11%)、CF(54.49%)、EE(2.00 %)、灰分(10.42%)、CHO(29.98%)和ME (156.0 kcal/100g)。靛蓝根的MC、DM、CP、CF、EE、灰分、CHO和ME含量分别为10.04%、89.60%、8.22%、40.88%、1.21%、8.43%、42.47%和210.0 kcal/100g。维生素分析表明,Indigofera tinctoria叶子,茎树皮和根含有β-胡萝卜素(8.45、2.88和5.11毫克/ 100克),维生素B1(1.94、0.33和1.00毫克/ 100克),维生素B2(0.71、0.21和0.50毫克/ 100克),维生素B3(0.66、0.34和0.48毫克/ 100克),维生素B6(0.32、0.21和0.30毫克/ 100克),维生素B7(0.63、0.01和0.16毫克/ 100克),维生素B9(0.26、0.10和0.18毫克/ 100克),维生素B12(0.21、0.03和0.10毫克/ 100克),维生素C(14.0、3.56和9.44毫克/ 100克),维生素D (0.10,0.01和0.06毫克/ 100克)和维生素K(0.17、0.07和0.12毫克/ 100克)。氨基酸分析显示苏氨酸,亮氨酸、赖氨酸、缬氨酸、色氨酸,甘氨酸、苯丙氨酸、组氨酸、甲硫氨酸,丙氨酸,丝氨酸,脯氨酸,天冬氨酸,谷氨酸,tryrosine和半胱氨酸Indigofera tinctoria叶子,茎皮和根(7.65%、1.22%和3.03%),(5.76、1.09%和2.46%),(3.11%、1.21%和2.00%),(7.21%、3.53%和4.09%),(1.45%、0.03%和1.00%),(4.76%,0.08%和2.33%),(6.33%、2.45%和3.49%),(7.42%、2.00%和3.00%),(3.49%、0.01%和2.00%),(2.41%、0.56%和1.20%),(5.23%、1.22%和1.76%),(2.87%、0.57%和1.00%),(5.32%、2.11%和3.56%),(9.66%、4.21%和5.11%),(2.45%、0.57%和1.67%),分别为(1.85%,0.81%和0.89%)。综上所述,紫靛叶、茎皮和根(叶、根、茎皮)均含有大量的营养物质、维生素和氨基酸。
{"title":"Chemical Evaluation of Proximate, Vitamin and Amino Acid Profile of Leaf, Stem Bark and Root of Indigofera Tinctoria","authors":"A. J.O","doi":"10.31579/2692-9406/026","DOIUrl":"https://doi.org/10.31579/2692-9406/026","url":null,"abstract":"Medicinal plants contain substances with high therapeutic value because they contain multiple bioactive chemicals. Chemical analysis of Indigofera tinctoria leaves, stem bark and roots was evaluated. The result revealed that proximate composition of Indigofera tinctoria leaves contained 12.49 % moisture content (M.C), 87.51 % dry matter (DM), 30.53 % crude protein (CP), 19.02 % crude fibre (CF), 2.44 % ether extract (EE), 13.86 % ash, 36.59 % carbohydrate (CHO) and 254.1 kcal/100g energy (ME). Indigofera tinctoria stem bark contained M.C (6.40 %), DM (93.60 %), CP (5.11 %), CF (54.49 %), EE (2.00 %), ash (10.42 %), CHO (29.98 %) and ME (156.0 kcal/100g). Indigofera tinctoria roots contained MC, DM, CP, CF, EE, ash, CHO and ME at 10.04 %, 89.60 %, 8.22 %, 40.88 %, 1.21 %, 8.43 %, 42.47 % and 210.0 kcal/100g respectively. Vitamin analysis showed that Indigofera tinctoria leaves, stem bark and roots contained β- carotene (8.45, 2.88 and 5.11 mg/100 g), Vitamin B1 (1.94, 0.33 and 1.00 mg/100 g), Vitamin B2 (0.71, 0.21 and 0.50 mg/100 g), Vitamin B3 (0.66, 0.34 and 0.48 mg/100 g), Vitamin B6 (0.32, 0.21 and 0.30 mg/100 g), Vitamin B7 (0.63, 0.01 and 0.16 mg/100 g), Vitamin B9 (0.26, 0.10 and 0.18 mg/100 g), Vitamin B12 (0.21, 0.03 and 0.10 mg/100 g), Vitamin C (14.0, 3.56 and 9.44 mg/100 g), Vitamin D (0.10, 0.01 and 0.06 mg/100 g) and Vitamin K (0.17, 0.07 and 0.12 mg/100 g). Amino acid analysis revealed the presence of threonine, leucine, lysine, valine, tryptophan, glycine, phenylalanine, histidine, methionine, alanine, serine, proline, aspartate, glutamic acid, tryrosine and cysteine in Indigofera tinctoria leaves, stem bark and roots at (7.65 %, 1.22 % and 3.03 %), (5.76, 1.09 % and 2.46 %), (3.11 %, 1.21% and 2.00 %), (7.21 %, 3.53 % and 4.09 %), (1.45%, 0.03% and 1.00 %), (4.76 %, 0.08 % and 2.33 %), (6.33 %, 2.45 % and 3.49 %), (7.42 %, 2.00 % and 3.00 %), (3.49 %, 0.01 % and 2.00 %), (2.41 %, 0.56 % and 1.20 %), (5.23 %, 1.22 % and 1.76 %), (2.87 %, 0.57 % and 1.00 %), (5.32 %, 2.11 % and 3.56 %), (9.66 %, 4.21 % and 5.11 %), (2.45 %, 0.57 % and 1.67 %) and (1.85 %, 0.81 % and 0.89 %) respectively. It was concluded that Indigofera tinctoria leaves, stem bark and roots are loaded with significant quantity of nutrients, vitamins and amino acid (leaves ˃ roots ˃ stem bark).","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44488388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Cases and Deaths: A Comparison among Bangladesh, India and Pakistan COVID-19病例和死亡:孟加拉国、印度和巴基斯坦的比较
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/043
B. M. Kibria
This paper compares the number of infected cases and deaths of an ongoing pandemic of COVID-19 outbreak for Bangladesh, India and Pakistan for the period of March 8, 2020 to September 21, 2020. Comparisons among countries using absolute numbers are not comparable due to different factors, such as population sizes, rates of per 100,000 and also because not all countries are affected equally and at the same time. Following Middelburg and Rosendaal (2020), we graphically compare the number of cases and deaths expressed as a percentage of the cases and deaths on the reference day 25 after the first reported death. To see the impact of reference days, several later reference days are also considered in this study. From these comparisons, clear differences were observed among countries. Among these three countries, it is observed that Bangladesh had the most extreme flattening of the curve, followed by Pakistan and then India. We observed that the epidemic developed in India much more rapidly as compare to Bangladesh and Pakistan.
本文比较了2020年3月8日至2020年9月21日期间孟加拉国、印度和巴基斯坦持续爆发的COVID-19大流行的感染病例和死亡人数。由于不同的因素,如人口规模、每10万人的死亡率,以及并非所有国家同时受到同等影响,使用绝对数字的国家之间的比较没有可比性。继Middelburg和Rosendaal(2020)之后,我们以图表形式比较了在首次报告死亡后的第25参考日,以病例和死亡的百分比表示的病例和死亡人数。为了观察参考日的影响,本研究还考虑了几个较晚的参考日。从这些比较中可以看出,各国之间存在明显差异。在这三个国家中,可以观察到,孟加拉国的曲线扁平化程度最高,其次是巴基斯坦,然后是印度。我们注意到,与孟加拉国和巴基斯坦相比,这种流行病在印度的发展要快得多。
{"title":"COVID-19 Cases and Deaths: A Comparison among Bangladesh, India and Pakistan","authors":"B. M. Kibria","doi":"10.31579/2692-9406/043","DOIUrl":"https://doi.org/10.31579/2692-9406/043","url":null,"abstract":"This paper compares the number of infected cases and deaths of an ongoing pandemic of COVID-19 outbreak for Bangladesh, India and Pakistan for the period of March 8, 2020 to September 21, 2020. Comparisons among countries using absolute numbers are not comparable due to different factors, such as population sizes, rates of per 100,000 and also because not all countries are affected equally and at the same time. Following Middelburg and Rosendaal (2020), we graphically compare the number of cases and deaths expressed as a percentage of the cases and deaths on the reference day 25 after the first reported death. To see the impact of reference days, several later reference days are also considered in this study. From these comparisons, clear differences were observed among countries. Among these three countries, it is observed that Bangladesh had the most extreme flattening of the curve, followed by Pakistan and then India. We observed that the epidemic developed in India much more rapidly as compare to Bangladesh and Pakistan.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric Stigma in Developing Societies 发展中社会的精神病污名
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/042
S. Shafti
Stigmatizing attitudes toward persons with mental syndromes are prevalent in the general population and even among mental health professionals, a problem that may result easily in public avoidance, constant discrimination, and declined help-seeking behavior. The effect of stigma is twofold: Public stigma is the response that the public has to people with mental disorder. Self-stigma is the bigotry which persons with mental disorder turn against themselves. The WHO has advised that stigma is one of the largest barricades to treatment engagement, even if management is operative, even in low-income nations. While before and according to a series of researches the outcome of severe mental illness is generally better in developing societies than in developed countries, and it has been suggested that stigma is less severe or non-existent in unindustrialized nations, the current studies and observations do not confirm such an optimistic hint and the idea that stigma attached to mental illness is a global phenomenon seems a reasonable inference. In the present article, the issue of stigmatization, deinstitutionalization, national goal setting, and real situation of various modules of psychiatric rehabilitation, in the context of social or public psychiatry, especially in developing countries, is discussed, from a practical point of view.
对精神综合症患者的污名化态度在一般人群中甚至在精神卫生专业人员中普遍存在,这一问题很容易导致公众回避、持续歧视和拒绝寻求帮助的行为。耻辱感的影响是双重的:公众耻辱感是公众对精神障碍患者的反应。自我耻辱是精神障碍患者对自己的偏见。世卫组织建议,污名是参与治疗的最大障碍之一,即使管理是有效的,即使在低收入国家也是如此。虽然之前和根据一系列研究,发展中社会的严重精神疾病的结果通常比发达国家好,并且有人认为,在非工业化国家,耻辱感不那么严重或不存在,但目前的研究和观察并没有证实这种乐观的暗示,与精神疾病相关的耻辱感是一种全球现象的想法似乎是一个合理的推论。在本文中,从实践的角度讨论了在社会或公共精神病学背景下,特别是在发展中国家,精神病康复的各种模块的污名化、去机构化、国家目标设定和实际情况。
{"title":"Psychiatric Stigma in Developing Societies","authors":"S. Shafti","doi":"10.31579/2692-9406/042","DOIUrl":"https://doi.org/10.31579/2692-9406/042","url":null,"abstract":"Stigmatizing attitudes toward persons with mental syndromes are prevalent in the general population and even among mental health professionals, a problem that may result easily in public avoidance, constant discrimination, and declined help-seeking behavior. The effect of stigma is twofold: Public stigma is the response that the public has to people with mental disorder. Self-stigma is the bigotry which persons with mental disorder turn against themselves. The WHO has advised that stigma is one of the largest barricades to treatment engagement, even if management is operative, even in low-income nations. While before and according to a series of researches the outcome of severe mental illness is generally better in developing societies than in developed countries, and it has been suggested that stigma is less severe or non-existent in unindustrialized nations, the current studies and observations do not confirm such an optimistic hint and the idea that stigma attached to mental illness is a global phenomenon seems a reasonable inference. In the present article, the issue of stigmatization, deinstitutionalization, national goal setting, and real situation of various modules of psychiatric rehabilitation, in the context of social or public psychiatry, especially in developing countries, is discussed, from a practical point of view.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Heart cardiac’s sounds signals segmentation by using the discrete wavelet transform (DWT) 基于离散小波变换(DWT)的心音信号分割
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/052
S. Debbal
The presence of abnormal sounds in one cardiac cycle, provide valuable information on various diseases.Early detection of various diseases is necessary; it is done by a simple technique known as: phonocardiography. The phonocardiography, based on registration of vibrations or oscillations of different frequencies, audible or not, that correspond to normal and abnormal heart sounds. It provides the clinician with a complementary tool to record the heart sounds heard during auscultation. The advancement of intracardiac phonocardiography, combined with signal processing techniques, has strongly renewed researchers’ interest in studying heart sounds and murmurs. This paper presents an algorithm based on the denoising by wavelet transform (DWT) and the Shannon energy of the PCG signal, for the detection of heart sounds (the first and second sounds, S1 and S2) and heart murmurs. This algorithm makes it possible to isolate individual sounds (S1 or S2) and murmurs to give an assessment of their average duration.
在一个心动周期中出现异常音,为各种疾病提供了有价值的信息。早期发现各种疾病是必要的;它是通过一种简单的技术来完成的:心音图。心音描记术,以记录不同频率的振动或振荡为基础,可听或不可听,这些振动或振荡对应于正常和异常的心音它为临床医生提供了一种辅助工具来记录听诊时听到的心音。心内语音心动图的进步,结合信号处理技术,强烈地重新燃起了研究人员对心音和杂音的兴趣。本文提出了一种基于小波变换(DWT)和PCG信号香农能量去噪的心音(第一声和第二声,S1和S2)和心音检测算法。该算法可以分离单个声音(S1或S2)和杂音,从而对其平均持续时间进行评估。
{"title":"Heart cardiac’s sounds signals segmentation by using the discrete wavelet transform (DWT)","authors":"S. Debbal","doi":"10.31579/2692-9406/052","DOIUrl":"https://doi.org/10.31579/2692-9406/052","url":null,"abstract":"The presence of abnormal sounds in one cardiac cycle, provide valuable information on various diseases.Early detection of various diseases is necessary; it is done by a simple technique known as: phonocardiography. The phonocardiography, based on registration of vibrations or oscillations of different frequencies, audible or not, that correspond to normal and abnormal heart sounds. It provides the clinician with a complementary tool to record the heart sounds heard during auscultation. The advancement of intracardiac phonocardiography, combined with signal processing techniques, has strongly renewed researchers’ interest in studying heart sounds and murmurs. This paper presents an algorithm based on the denoising by wavelet transform (DWT) and the Shannon energy of the PCG signal, for the detection of heart sounds (the first and second sounds, S1 and S2) and heart murmurs. This algorithm makes it possible to isolate individual sounds (S1 or S2) and murmurs to give an assessment of their average duration.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-COV-2/COVID19 Induce Kawasaki-Like Disease in Children Experience of Republic of Moldova: A Report of Five Cases SARS-COV-2/ covid - 19在摩尔多瓦共和国儿童中诱发川崎样病的经验:附5例报告
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/055
N. Revenco
Infection with SARS-CoV-2 virus is a serious challenge for the entire medical and scientific community. Medical institutions are facing record numbers of patients and conflicting claims about SARS-CoV-2 and due to its mutagenic properties, thanks to the D614G protein from Coronavirus (CoV) defining the determines the mutagenicity of SARS - CoV and MERS-CoV [1,2]. With the expansion of the COVID-19 Pandemic, researchers have reported [3] clinical cases of multisystemic inflammatory syndrome in children (MIS-C), similar to Kawasaki disease (KD). Due to the absence of a diagnostic marker for KD, the latter is established according to the criteria of the American Society of Cardiology, in this situation with associated SARS-CoV-2 infection. We deem it appropriate to report five clinical cases of KD that met the criteria for defining an MIS-C case as defined by WHO.
感染SARS-CoV-2病毒是整个医学界和科学界面临的严峻挑战。由于冠状病毒(CoV)中的D614G蛋白定义了SARS-CoV和MERS-CoV的致突变性,医疗机构正面临着创纪录的患者数量和关于SARS-CoV-2的相互矛盾的说法,并且由于其致突变性[1,2]。随着COVID-19大流行的扩大,研究人员报告了100例儿童多系统炎症综合征(MIS-C)临床病例,类似于川崎病(KD)。由于缺乏KD的诊断标志物,后者是根据美国心脏病学会的标准建立的,在这种情况下伴有SARS-CoV-2感染。我们认为报告符合世卫组织定义的misc病例标准的5例临床KD病例是合适的。
{"title":"SARS-COV-2/COVID19 Induce Kawasaki-Like Disease in Children Experience of Republic of Moldova: A Report of Five Cases","authors":"N. Revenco","doi":"10.31579/2692-9406/055","DOIUrl":"https://doi.org/10.31579/2692-9406/055","url":null,"abstract":"Infection with SARS-CoV-2 virus is a serious challenge for the entire medical and scientific community. Medical institutions are facing record numbers of patients and conflicting claims about SARS-CoV-2 and due to its mutagenic properties, thanks to the D614G protein from Coronavirus (CoV) defining the determines the mutagenicity of SARS - CoV and MERS-CoV [1,2]. With the expansion of the COVID-19 Pandemic, researchers have reported [3] clinical cases of multisystemic inflammatory syndrome in children (MIS-C), similar to Kawasaki disease (KD). Due to the absence of a diagnostic marker for KD, the latter is established according to the criteria of the American Society of Cardiology, in this situation with associated SARS-CoV-2 infection. We deem it appropriate to report five clinical cases of KD that met the criteria for defining an MIS-C case as defined by WHO.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Patient-Centric Care Approach to Facilitate the Design of an Artificial Intelligence Application in Geriatric Care Management of Heart Failure Readmissions 以患者为中心的护理方法促进人工智能在心力衰竭再入院老年护理管理中的应用设计
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/056
T. Wan
The examination of human factors’ role in moderating medical interventions and hospitalizations and/or rehospitalization of heart failure (HF) patients. Objectives: The primary purpose of this study is two-fold: 1) to show relevant human factors influencing the rehospitalization of persons with heart failure by developing a systematic algorithm generated from the cited randomized trials; and 2) to examine how the self-care principles, such as choice/efficacy, restfulness, healing environment, activity, trust, interpersonal relationships, outlook, and nutrition, may reduce heart failure readmissions. Methods: The meta-analytic approach generated a theoretically relevant and empirically validated self-care management decision support protocol for HF. Statistical modeling of the effects of eight human factors for the reduction of HF readmissions was presented. Findings: The systematic review and meta-analysis approach documents the results of randomized clinical trials that affect heart failure hospitalization by selected human factors. A patient-centered decision support system was developed to facilitate the self-care management of heart failure. Discussion: Our research generates systematic knowledge about the importance of human-factor principles in the provision of geriatric care for heart failure. Using shared decision-making strategies under the population health management approach could enhance the quality of care and reduce costly readmissions of heart failure, particularly for elderly patients.
人为因素在减缓心力衰竭(HF)患者的医疗干预和住院和/或再住院中的作用的研究目的:本研究的主要目的有两个:1)通过从引用的随机试验中生成的系统算法来显示影响心力衰竭患者再住院的相关人为因素;2)研究自我护理原则,如选择/疗效、休息、治疗环境、活动、信任、人际关系、前景和营养,如何减少心力衰竭再入院。方法:荟萃分析方法生成了一个理论相关和经验验证的心衰自我保健管理决策支持方案。提出了8种人为因素对减少心衰再入院影响的统计模型。研究结果:系统回顾和荟萃分析方法记录了随机临床试验的结果,这些结果与选定的人为因素影响心力衰竭住院治疗有关。为促进心衰患者的自我护理管理,开发了以患者为中心的决策支持系统。讨论:我们的研究产生了关于人为因素原则在提供老年心力衰竭护理中的重要性的系统知识。在人口健康管理方法下使用共享决策策略可以提高护理质量并减少心力衰竭的再入院费用,特别是对老年患者。
{"title":"A Patient-Centric Care Approach to Facilitate the Design of an Artificial Intelligence Application in Geriatric Care Management of Heart Failure Readmissions","authors":"T. Wan","doi":"10.31579/2692-9406/056","DOIUrl":"https://doi.org/10.31579/2692-9406/056","url":null,"abstract":"The examination of human factors’ role in moderating medical interventions and hospitalizations and/or rehospitalization of heart failure (HF) patients. Objectives: The primary purpose of this study is two-fold: 1) to show relevant human factors influencing the rehospitalization of persons with heart failure by developing a systematic algorithm generated from the cited randomized trials; and 2) to examine how the self-care principles, such as choice/efficacy, restfulness, healing environment, activity, trust, interpersonal relationships, outlook, and nutrition, may reduce heart failure readmissions. Methods: The meta-analytic approach generated a theoretically relevant and empirically validated self-care management decision support protocol for HF. Statistical modeling of the effects of eight human factors for the reduction of HF readmissions was presented. Findings: The systematic review and meta-analysis approach documents the results of randomized clinical trials that affect heart failure hospitalization by selected human factors. A patient-centered decision support system was developed to facilitate the self-care management of heart failure. Discussion: Our research generates systematic knowledge about the importance of human-factor principles in the provision of geriatric care for heart failure. Using shared decision-making strategies under the population health management approach could enhance the quality of care and reduce costly readmissions of heart failure, particularly for elderly patients.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Tako-Tsubo syndrome. Approach to the subject and Report of 2 cases Tako-Tsubo综合症。本课题的处理方法及2例报告
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/074
C. Pazos
Takotsubo syndrome, or stress cardiomyopathy, is a relatively rare transient and reversible cardiomyopathy, although its diagnosis has increased in recent years, it presents as an acute coronary syndrome (ACS) or acute heart failure, its incidence is unknown exactly in Latin America and in Cuba. We present 2 cases seen in our hospital, both 63 and 55-year-old women with typical precordial pressure pain, the first triggering psychological stress and the second physical, with electrocardiographic changes consistent with anterior infarction and cardiogenic shock, which were found in the coronary angiographic study observed normal coronary arteries and ventriculography determined apical ballooning of the left ventricle characteristic of the syndrome, with subsequent recovery and favorable clinical evolution at 6 months.
Takotsubo综合征,或应激性心肌病,是一种相对罕见的短暂性和可逆性心肌病,尽管近年来其诊断有所增加,但其表现为急性冠脉综合征(ACS)或急性心力衰竭,其在拉丁美洲和古巴的确切发病率尚不清楚。本文报告我院收治的2例患者,年龄均为63岁和55岁,均为典型的心前压痛,1例为引发心理应激,2例为引发生理应激,心电图变化符合前路梗死和心源性休克,冠状动脉造影观察到冠状动脉正常,心室造影确定为左心室心尖球囊化综合征的特征性表现。6个月后恢复,临床进展良好。
{"title":"Tako-Tsubo syndrome. Approach to the subject and Report of 2 cases","authors":"C. Pazos","doi":"10.31579/2692-9406/074","DOIUrl":"https://doi.org/10.31579/2692-9406/074","url":null,"abstract":"Takotsubo syndrome, or stress cardiomyopathy, is a relatively rare transient and reversible cardiomyopathy, although its diagnosis has increased in recent years, it presents as an acute coronary syndrome (ACS) or acute heart failure, its incidence is unknown exactly in Latin America and in Cuba. We present 2 cases seen in our hospital, both 63 and 55-year-old women with typical precordial pressure pain, the first triggering psychological stress and the second physical, with electrocardiographic changes consistent with anterior infarction and cardiogenic shock, which were found in the coronary angiographic study observed normal coronary arteries and ventriculography determined apical ballooning of the left ventricle characteristic of the syndrome, with subsequent recovery and favorable clinical evolution at 6 months.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70019178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluid Therapy (FT) Complications: Volumetric Overload (VO) in the patho-Aetiology of VO Shocks (VOS) and the Acute Respiratory Distress Syndrome (ARDS) 液体治疗(FT)并发症:容量过载(VO)在VO休克(VOS)和急性呼吸窘迫综合征(ARDS)的病理病因学中的作用
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/037
A. Ghanem
Fluid therapy (FT) was introduced during WW2. Ever since its complications have been frequently reported but notably some serious complications have been overlooked. The role of volumetric overload (VO) in inducing VU shocks (VOS) and causing the acute respiratory distress syndrome (ARDS) has remained overlooked, unrecognized, and underestimated till recently. The role of FT complications in inducing VOS and causing ARDS is hard to detect because VOS is a shock that complicates another existing shock seamlessly and un-noticed. The author attributes this to the faulty rules on FT dictated by the wrong Starling’s law that causes many errors and misconceptions of FT which mislead physicians into giving too much fluid during shock resuscitation. The research findings on the wrong Starling’s law and how it has been corrected based on the hydrodynamic of the porous orifice (G) tube and the newly recognized VOS and the new patho-aetiology and therapy of ARDS are summarized here. Other authors in support of this contention are quoted. The errors on current FT and its corrections are given. Finally, a new prospective cohort study on FT and ARDS is recommended and a call for new guidelines on FT is urgently needed.
液体疗法(FT)在二战期间被引入。自那时以来,其并发症已被频繁报道,但值得注意的是,一些严重的并发症被忽视了。容量过载(VO)在诱发VU冲击(VOS)和引起急性呼吸窘迫综合征(ARDS)中的作用一直被忽视、未被认识和低估。FT并发症在诱发VOS和引起ARDS中的作用很难发现,因为VOS是一种无缝且不被注意的使另一种现有休克复杂化的休克。作者将此归因于错误的斯塔林定律(Starling’s law)对金融时报的错误规定,这导致了许多错误和对金融时报的误解,误导医生在休克复苏期间给予过多的液体。本文从G管的流体力学和新认识的VOS以及ARDS的新病理病因和治疗方法等方面综述了有关Starling定律错误的研究成果及其纠正方法。引用了支持这一论点的其他作者。给出了当前傅立叶变换的误差及其修正。最后,我们建议对FT和ARDS进行一项新的前瞻性队列研究,并迫切需要制定新的FT指南。
{"title":"Fluid Therapy (FT) Complications: Volumetric Overload (VO) in the patho-Aetiology of VO Shocks (VOS) and the Acute Respiratory Distress Syndrome (ARDS)","authors":"A. Ghanem","doi":"10.31579/2692-9406/037","DOIUrl":"https://doi.org/10.31579/2692-9406/037","url":null,"abstract":"Fluid therapy (FT) was introduced during WW2. Ever since its complications have been frequently reported but notably some serious complications have been overlooked. The role of volumetric overload (VO) in inducing VU shocks (VOS) and causing the acute respiratory distress syndrome (ARDS) has remained overlooked, unrecognized, and underestimated till recently. The role of FT complications in inducing VOS and causing ARDS is hard to detect because VOS is a shock that complicates another existing shock seamlessly and un-noticed. The author attributes this to the faulty rules on FT dictated by the wrong Starling’s law that causes many errors and misconceptions of FT which mislead physicians into giving too much fluid during shock resuscitation. The research findings on the wrong Starling’s law and how it has been corrected based on the hydrodynamic of the porous orifice (G) tube and the newly recognized VOS and the new patho-aetiology and therapy of ARDS are summarized here. Other authors in support of this contention are quoted. The errors on current FT and its corrections are given. Finally, a new prospective cohort study on FT and ARDS is recommended and a call for new guidelines on FT is urgently needed.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70018334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stigma towards Patients with Chronic Obstructive Pulmonary Disease: To Help or To Judge? 慢性阻塞性肺疾病患者的耻辱感:帮助还是判断?
Pub Date : 2021-01-01 DOI: 10.31579/2692-9406/063
I. Khan
Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of mortality worldwide, is a highly incapacitating irrevocable health problem, with pulmonary and extra-pulmonary manifestations. According to Suzanne Hurd and Claude Lenfant, it is “the only chronic disease for which the finger of blame can be pointed to a single risk factor – tobacco smoking”. However, only 15-20% of smokers are afflicted. Whereas smoking is far from being the only cause, substantial proportion of COPD cases cannot be explained by smoking alone. The visibility of distressing and frightening physical manifestations of symptoms leads to serious ‘‘observable’’ consequences, such as disability or lack of control, public use of oxygen and rescue inhalers. As a result “they are disqualified from full social acceptance”. However, the stigma is not the only factor responsible for the miseries of those with COPD. In fact, there are many misconceptions in this scenario which have been discussed. The need of a huge awareness campaign for the public to improve their understanding of lung diseases (notably COPD) has been highlighted. The patient, healthcare professionals and the health services should be prepared to play their new role in the management of a chronic disease like COPD “requiring “ongoing management over a period of years or decades”. The importance of a self-management strategy has been emphasised.
慢性阻塞性肺病(COPD)是全球第三大死亡原因,是一种高度致残的、不可逆转的健康问题,具有肺部和肺外表现。根据苏珊娜·赫德和克劳德·伦凡特的说法,这是“唯一一种可以将责任归咎于单一风险因素——吸烟的慢性病”。然而,只有15-20%的吸烟者受到影响。虽然吸烟远不是唯一的原因,但很大一部分慢性阻塞性肺病病例不能仅仅用吸烟来解释。令人痛苦和可怕的身体症状的可见性导致严重的"可观察到的"后果,例如残疾或缺乏控制,公共场合使用氧气和救援吸入器。因此,“他们没有资格获得完全的社会认可”。然而,污名并不是造成COPD患者痛苦的唯一因素。事实上,在这个场景中有许多已经讨论过的误解。已强调需要开展大规模的提高公众认识运动,以提高他们对肺部疾病(特别是慢性阻塞性肺病)的了解。患者、卫生保健专业人员和卫生服务机构应做好准备,在管理慢性阻塞性肺病等慢性病方面发挥新的作用”,需要“持续管理数年或数十年”。自我管理战略的重要性已得到强调。
{"title":"Stigma towards Patients with Chronic Obstructive Pulmonary Disease: To Help or To Judge?","authors":"I. Khan","doi":"10.31579/2692-9406/063","DOIUrl":"https://doi.org/10.31579/2692-9406/063","url":null,"abstract":"Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of mortality worldwide, is a highly incapacitating irrevocable health problem, with pulmonary and extra-pulmonary manifestations. According to Suzanne Hurd and Claude Lenfant, it is “the only chronic disease for which the finger of blame can be pointed to a single risk factor – tobacco smoking”. However, only 15-20% of smokers are afflicted. Whereas smoking is far from being the only cause, substantial proportion of COPD cases cannot be explained by smoking alone. The visibility of distressing and frightening physical manifestations of symptoms leads to serious ‘‘observable’’ consequences, such as disability or lack of control, public use of oxygen and rescue inhalers. As a result “they are disqualified from full social acceptance”. However, the stigma is not the only factor responsible for the miseries of those with COPD. In fact, there are many misconceptions in this scenario which have been discussed. The need of a huge awareness campaign for the public to improve their understanding of lung diseases (notably COPD) has been highlighted. The patient, healthcare professionals and the health services should be prepared to play their new role in the management of a chronic disease like COPD “requiring “ongoing management over a period of years or decades”. The importance of a self-management strategy has been emphasised.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70019128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical research and clinical reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1